Assembly Biosciences, Inc (ASMB)
NASDAQ · Manufacturing · Pharmaceutical preparations
$23.67+$0.0100 (+0.04%) on the dayAs of the close; data may be delayed.
ASMB price, last 12 months
Key stats
- Previous close
- $23.66
- Open
- $23.70
- Day range
- $23.43 – $24.25
- 52-week range
- $21.80 – $39.71
- Volume
- 143.5K
- Avg volume (20 days)
- 394.1K
- Market cap
- $481.9M
Performance
1W−5.2%
1M−33.2%
3M−11.5%
6M−18.0%
YTD−30.4%
1Y−7.8%
vs S&P 500, 1Y−24.5 pts
Technicals and fundamentals
About Assembly Biosciences, Inc
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $481.9M